<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-09-21T15:36:23Z</responseDate>
  <request verb="GetRecord" identifier="oai:salford-repository.worktribe.com:1337324" metadataPrefix="uketd_dc">salford-repository.worktribe.com</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:salford-repository.worktribe.com:1337324</identifier>
        <datestamp>2026-06-03T21:33:42Z</datestamp>
        <setSpec>084104101115105115</setSpec>
        <setSpec>openaccess</setSpec>
      </header>
      <metadata>
        <uketd_dc:uketddc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:uketd_dc="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/" xmlns:uketdterms="http://naca.central.cranfield.ac.uk/ethos-oai/terms/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:type>Thesis</dc:type>
          <dc:title>Establishing a structure-activity-relationship for small molecule non-sugar glycomimetics</dc:title>
          <dcterms:abstract>DAOY Medullablastoma cells are highly invasive, mobile and can cause severe neurological and physical illness in patients affected by this cancer. Previous work by Wilkinson &amp; Co-workers (2017) showed that some small-molecule non-sugar glycomimetic drugs were able to prevent wound healing in DAOY cells. Therefore establishing a SAR for these molecules was of interest.A number of mono, di, tri, tetra &amp; poly-sulfated drug molecules were synthesised from easily available starting materials and reagents and tested for potency against wound healing in DAOY cells in a scratch assay against human growth factor/scatter factor (HGF/SF) as a control. Compounds trialled in scratch assays did not show any reasonable biological activity. HGF/SF has been shown to activate downstream signalling of the oncogene product c-Met which is a biomarker for cancer(s) and can be associated with poorer outcomes for patients.</dcterms:abstract>
          <dc:creator>Dobiecki-Davies, J</dc:creator>
          <uketdterms:qualificationlevel>Master's Level (Level 7)</uketdterms:qualificationlevel>
          <dcterms:dateAccepted>2021-03-31</dcterms:dateAccepted>
          <dc:identifier>oai:salford-repository.worktribe.com:1337324</dc:identifier>
          <dc:identifier xsi:type="dcterms:URI">https://salford-repository.worktribe.com/file/1337324/1/Joe%20Dobiecki-Davies%20MSc%20final%20copy.pdf</dc:identifier>
          <uketdterms:sponsor>Kidscan</uketdterms:sponsor>
          <dcterms:isReferencedBy>https://salford-repository.worktribe.com/output/1337324</dcterms:isReferencedBy>
          <dcterms:issued>2021</dcterms:issued>
          <dc:language>en</dc:language>
          <dc:licence>openAccess</dc:licence>
          <dcterms:accessRights>Public</dcterms:accessRights>
        </uketd_dc:uketddc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
